1494 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
RSS Create an RSS feed from your search for:
"Sexually Transmitted Diseases, Viral"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
4 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
5 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
6 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
7 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
8 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
9 Recruiting Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
Condition: AIDS Dementia Complex
Intervention: Drug: Ferumoxytol
10 Not yet recruiting A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction
Conditions: HIV (Human Immuno-Deficiency Virus);   Renal Impairment;   ESRD (End-Stage Renal Disease)
Intervention: Drug: Oral BMS-663068 (pro-drug), metabolized to active BMS-626529
11 Completed Dose Optimisation of Stavudine for the Treatment of HIV Infection
Conditions: Acquired Immune Deficiency Syndrome;   Human Immunodeficiency Virus
Interventions: Drug: Stavudine;   Drug: Tenofovir Disoproxil Fumarate
12 Not yet recruiting Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: Placebo for VRC01
13 Not yet recruiting HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection
Conditions: Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: E/C/F/TAF;;   Drug: Ledipasvir-Sofosbuvir
14 Not yet recruiting Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs
Condition: Human Immunodeficiency Virus
Intervention: Drug: dolutegravir/abacavir/lamivudine
15 Not yet recruiting Metformin Immunotherapy in HIV Infection
Condition: HIV Infection
Intervention: Drug: Metformin
16 Recruiting Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
Condition: HIV
Interventions: Drug: Dolutegravir;   Drug: Emtricitabine/Tenofovir
17 Recruiting Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia
Condition: Human Immunodeficiency Virus
Interventions: Drug: Boosted atazanavir;   Drug: Lamivudine
18 Recruiting CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
Condition: HIV, Inflammation
Interventions: Drug: Assess Safety;   Drug: Effect of drug on viral load;   Drug: Effect of drug on T-cell count;   Drug: Effect of drug on inflammatory biomarkers
19 Not yet recruiting Safety and Efficacy of Allogenic Adoptive Cell Therpy for Immunodeficiency in Chronic HIV-1 Infected Patients
Conditions: Human Immunodeficiency Virus;   Immunosuppression
Interventions: Other: Conventional plus AAC treatment;   Other: Conventional plus placebo treatment
20 Not yet recruiting Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
Conditions: Hepatitis C;   Human Immunodeficiency Virus
Interventions: Drug: ledipasvir and sofosbuvir;   Drug: Placebo (for ledipasvir and sofosbuvir)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years